Shoulder Innovations Q3 revenue up 58% to $11.8M; raises FY25 guidance to $45-46M

SHOULDER INNOVATIONS, INC.

2025-Q3 EPS reported -$7.00 vs consensus -$0.32 ▼ miss (-2106.8%)

Revenue $11.8M (+58% YoY); net loss $8.7M vs $4.1M loss in Q3 2024.
Gross margin 76.2%; sold 1,584 implant systems (+53% YoY).
Raises full-year 2025 revenue guidance to $45M-$46M from prior $42M-$44M.
Cash $137M after IPO and convertible notes; FDA clearance for fracture indications.
Adjusted EBITDA loss $7.5M vs $2.9M loss; SG&A $15.1M up 78% YoY on growth investments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.